DRG Instruments GmbH, founded in 1973 as a subsidiary of DRG Intl. Inc., USA, is a diagnostics manufacturer and distributor with successful operations in over 110 countries.
The DRG Group focuses on high technology medical diagnostic areas such as Diabetes Diagnosis, Gynecology, Oncology, Immunology, Infectious Diseases and Toxicology.
The highly skilled DRG staff of medical, clinical, marketing and service specialists is experts at taking innovative technology to market through local territory knowledge and contacts, end-user training, education and cost effective financial and logistical support. The DRG-Development and Immunoassay production facilities are located in Marburg, Germany, in addition to OEM manufacturing in the USA.
A wide range of new, occasionally unique, ELISA kits have been developed. The DRG ELISA kits compete effectively in both price and performance in all major world diagnostics markets. To complete the diagnostic reagent line, DRG supplies the clinical laboratory with all necessary equipment, including a semi-automated microtiterplate processor, the DRG E-LizaMat 3000, and fully automated Open Systems for microtiterplates, which are fully compatible with all Elisas.
DRG offers the FIRST fully automated Analyzer for Immunoassays, Clinical Chemistry and Immunoturbidimetry: DRG:HYBRiD-XL®.
The DRG Group operates through a network of DRG Subsidiary Companies in Germany, Poland, Russia, and the Czech Republic, and through Distributors in Europe, the Middle East, Asia, Africa and the Pacific Region. This infrastructure offers access to specialized medical markets in most major countries around the world.